To begin testing the clinical significance of JAM-A expression in HER2-positive gastric cancer patient cases, we used an open-source online gene expression data resource (http://kmplot.com (accessed on 3 July 2019)) [20]. This evidence concerns the gene ERBB2 and gastric cancer.